Study of Embryotoxic and Teratogenic Action of the Medicinal Form of Capsule UROCONITE-0.2 G

Ganieva Z.B., Fayzieva Z.T.

Abstract: The authors studied the embryotoxic and teratogenic effects of the capsule Uroconite-0.2 g. The results of the study proved that the studied capsule - Uroconite-0.2 g in doses of 100 and 500 mg/kg does not adversely affect the development of the fetus in experimental animals. Therefore, the capsule Uroconite-0.2 g does not involve embryotoxic and teratogenic effects.

Keywords: Uroconite-02 g, embryotoxicity, teratogenicity, fetus, pathology and anomalies